The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| SERA | -47.93% | N/A | N/A | -69% |
| S&P | +16.9% | +95.99% | +14.39% | +56% |
Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.02M | -29.2% |
| Gross Profit | -$0.23M | 32.6% |
| Gross Margin | -1364.71% | 68.6% |
| Market Cap | $104.35M | -45.9% |
| Market Cap / Employee | $1.63M | 0.0% |
| Employees | 64 | 12.3% |
| Net Income | -$8.05M | 3.1% |
| EBITDA | -$9.08M | -2.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $5.02M | 7.5% |
| Accounts Receivable | $0.02M | -83.2% |
| Inventory | 0 | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00M | -100.0% |
| Short Term Debt | $0.35M | -65.1% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -33.28% | 1.5% |
| Return On Invested Capital | -172.77% | 6.5% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$5.75M | 3.0% |
| Operating Free Cash Flow | -$5.47M | 7.7% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 4.82 | 5.03 | 2.63 | 1.10 | -63.03% |
| Price to Sales | 2781.67 | 3587.89 | 1342.98 | 1258.46 | -30.93% |
| Price to Tangible Book Value | 4.82 | 5.03 | 2.69 | 1.11 | -63.04% |
| Enterprise Value to EBITDA | -24.57 | -25.06 | -12.04 | -10.58 | -35.19% |
| Return on Equity | -49.6% | -55.8% | -41.4% | -44.2% | -1.18% |
| Total Debt | $1.10M | $0.84M | $0.57M | $0.35M | -74.13% |
SERA earnings call for the period ending June 30, 2022.
SERA earnings call for the period ending March 31, 2022.
SERA earnings call for the period ending December 31, 2021.
SERA earnings call for the period ending September 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
